Patricia C. Lloyd

US Food and Drug Administration

Poster(s):

• (257) Background Rates of Adverse Events of Special Interest for COVID-19 Vaccine Safety Monitoring Among Adults in the United States
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (253) Combining COVID-19 Vaccine Data from Claims with Data from Immunization Information Systems (IIS) to Address Exposure Misclassification: An Approach Within the FDA Biologics Effectiveness and Safety (BEST) Initiative
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (294) Reduction in Data Lag Using Optum Pre-Adjudicated Health Insurance Claims
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (136) Validation of an Algorithm for Unusual Site Thrombosis with Thrombocytopenia Syndrome (TTS) Within Electronic Health Records (EHRs)
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST